BET bromodomain inhibitor 1, CAS [[2411226-02-1]]

Produktübersicht

• Artikelname: BET bromodomain inhibitor 1, CAS [[2411226-02-1]]
• Artikelnummer: MCE-HY-131061
• Hersteller Artikelnummer: HY-131061
• Alternativnummer: MCE-HY-131061-25MG,MCE-HY-131061-50MG,MCE-HY-131061-5MG,MCE-HY-131061-10MG,MCE-HY-131061-100MG,MCE-HY-131061-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

BET bromodomain inhibitor 1 is an orally active, selective bromodomain and extra-terminal (BET) bromodomain inhibitor with an IC50 of 2.6 nM for BRD4. BET bromodomain inhibitor 1 binds to BRD2(2), BRD3(2), BRD4(1), BRD4(2), and BRDT(2) with high affinities (Kd values of 1.3 nM, 1.0 nM, 3.0 nM, 1.6 nM, 2.1 nM, respectively). bromodomain inhibitor 1 has anti-cancer activity[1].

Produkteigenschaften

• Molekulargewicht: 459.47
• Reinheit: 99.91
• CAS Nummer: [2411226-02-1]
• Formel: C22H19F2N3O4S
• Target-Kategorie: Epigenetic Reader Domain

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound